Health: Tuberculosis

Baroness Sheehan Excerpts

Thursday 29th November 2018 Lords Chamber

[Lord Bates]

I believe that the specific case in Uganda, which the noble Lord raised with me, has now been resolved through the Global Drug Facility. A six-month supply of the drug has been provided, following the closure of the factory in China which was the principal supplier. We keep that under review through the World Health Organization. The noble Lord also asked what more we could be doing in that area to close the funding gap. The Secretary of State, Penny Mordaunt, attended a very successful UN General Assembly high-level meeting specifically on tackling TB at the margins, where a target was set for a level of treatment and funding. At that event, the Secretary of State also announced further funding, from us, of £7.5 million for the TB Alliance.

[Baroness Sheehan (LD)]

My Lords, earlier this year I visited a lab in London that is at the centre of efforts to develop HIV and TB vaccines, run under the auspices of the International AIDS Vaccine Initiative. Since then, breakthrough clinical trials have shown that an effective TB vaccine could be possible but, despite this, the Government no longer fund this work. Yet we know that without vaccines, we will not end the epidemics. Will the Minister revisit this decision so that we can support UK science and deliver on our SDG promise to end TB by 2030?

[Lord Bates]

We work closely with my noble friend at the Department of Health and Social Care on the specifics of vaccines. DfID has funded some candidates for potential vaccines in the past. It is a very long-term project. There is such demand for scarce resources that we have to allocate them correctly, but if there are promising candidates for a vaccine we would very much want to look at the possibility of funding them.